Novo Nordisk is intervening in the lawsuit filed by a drug compounders trade group against the FDA over the agency’s decision ...
Despite falling hard since last summer, shares of Novo Nordisk have more than doubled the market's overall performance. The ...
Walgreens jumps as Sycamore agrees to $11.45 a share purchase Sycamore Partners agreed to acquire Walgreens Boots (WBA) in a ...
While the Super Bowl may not always be the ideal spot for pharma, cultural events like the Oscars can offer a more ...
Despite comments made by a Novo Nordisk official this week, the company confirmed to BioSpace that it has no additional ...
A federal court in Texas has rejected a request by producers of compounded drugs to extend their ability to manufacture ...
Novo Nordisk has asked the FDA to stop compounding ... The request follows a similar move by Eli Lilly, which has asked for a ban on other parties making copies of its tirzepatide-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback